Provided by Tiger Trade Technology Pte. Ltd.

Cyclacel Pharmaceuticals

5.05
0.0000
Volume:- -
Turnover:- -
Market Cap:1.69M
PE:-125.44
High:5.05
Open:5.05
Low:5.05
Close:5.05
52wk High:17.00
52wk Low:3.29
Shares:335.30K
Float Shares:335.30K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0403
EPS(LYR):-33.4976
ROE:-1950.23%
ROA:-160.18%
PB:0.55
PE(LYR):-0.15

Loading ...

Jul 24, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 07, 2023

Major Issues Report

Form 8-K - Current report
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2023

Major Issues Report

Form 8-K - Current report
Mar 13, 2023

Major Issues Report

Form 8-K - Current report
Mar 09, 2023

Major Issues Report

Form 8-K - Current report
Mar 08, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 06, 2023

Major Issues Report

Form 8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 06, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 26, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 06, 2023

Major Issues Report

Form 8-K - Current report
Dec 30, 2022

Major Issues Report

Form 8-K - Current report
Dec 09, 2022

Major Issues Report

Form 8-K - Current report
Nov 10, 2022

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2022

Major Issues Report

Form 8-K - Current report
Oct 31, 2022

Major Issues Report

Form 8-K - Current report